Citation Impact
Citing Papers
Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer
2007
Gene expression profiling of breast cell lines identifies potential new basal markers
2005
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
2009
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Down-regulation of Laminin-Binding Integrins by 1α,25=Dihydroxyvitamin D3in Human Melanoma Cells in Vitro
1998
EGFR Antagonists in Cancer Treatment
2008 Standout
ErbB-targeted therapeutic approaches in human cancer
2003
Contributions of the epidermal growth factor receptor to keratinocyte motility
1998
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate
2011
Epidermal growth factor receptor tyrosine kinase
1994
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
High Prevalence of Vitamin D Inadequacy and Implications for Health
2006 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
2008 Standout
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Technical considerations for studying cancer metastasis in vivo
1997
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Head and neck cancer
2008 Standout
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
Epidermal Growth Factor Receptor Activation under Oxidative Stress Fails to Promote c-Cbl Mediated Down-regulation
2002
Vitamin D Deficiency
2007 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
2006 Standout
Stem cells find their niche
2001 StandoutNature
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2
2006
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
2008 Standout
Extracellular Matrix Degradation and Remodeling in Development and Disease
2011 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
2012 StandoutNobel
Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck
1998
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
2004 Standout
Protein kinases — the major drug targets of the twenty-first century?
2002 Standout
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells
1998 Standout
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men
2006 Standout
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
2008 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Cell-Matrix Interactions in Mammary Gland Development and Breast Cancer
2010
Chemistry in living systems
2005 StandoutNobel
Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck
1996
The Biology of Hair Follicles
1999 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Specificity and mechanism of action of some commonly used protein kinase inhibitors
2000 Standout
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas
1997
Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination
2003
An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet‐B radiation
2002
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Cancer as an evolutionary and ecological process
2006 Standout
Clinical targets for anti-metastasis therapy
2000
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Epidermal Growth Factor Receptor (EGFR) Antibody Down-regulates Mutant Receptors and Inhibits Tumors Expressing EGFR Mutations
2006
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
Epidermal growth factor receptor expression in primary laryngeal cancer: An independent prognostic factor of neck node relapse
1999
Vitamin D deficiency: a worldwide problem with health consequences
2008 Standout
Regulation of In Situ to Invasive Breast Carcinoma Transition
2008
Life and Death Decisions: Ceramide Generation and EGF Receptor Trafficking Are Modulated by Oxidative Stress
2004
Velvet, a Dominant Egfr Mutation That Causes Wavy Hair and Defective Eyelid Development in Mice
2004 StandoutNobel
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer
2007 Standout
Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.
1995
Monoclonal Antibody Therapy for Cancer
2003
The Role of Vitamin D in Cancer Prevention
2005 Standout
BindingDB Entry 50022536: Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.
2025
Controls of Hair Follicle Cycling
2001 Standout
Epidermal growth factor receptor exposed to cigarette smoke is aberrantly activated and undergoes perinuclear trafficking
2007
Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy.
1999
Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice
2000
Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia
2002
Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1.
2001
Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
1998
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Plakoglobin Suppresses Epithelial Proliferation and Hair Growth in Vivo
2000 StandoutNobel
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
2004 Standout
Works of J Sandle being referenced
Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy.
1995
The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma
1993
Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers
2006
Cytokeratin 5/6 in normal human breast: lack of evidence for a stem cell phenotype
2004
Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer
1993
Preclinical models for the evaluation of targeted therapies of metastatic disease
1994
Myoepithelial Cells: Pathology, Cell Separation and Markers of Myoepithelial Differentiation
2005
Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
1994